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Absract 
A stakeholder sllrvev was conducted in  Ghana to assess the level of  public 
perceptions and acceptance of  agricultural biotechnologies.  A  total of 100 
respondents  drawn from  academia,  Non-governmental organizations,  busi-
ness community. government and other stakeholders were interviewed on their 
views Oil se!f-protection attitudes. health and economic benefits. skeptisl11  and 
optimism about agricllltural biotechnologies as well as the level of  confidence 
in  e:risting government reglllatorv systems to protect society against an)  neg-
ative  effects of biotechnological issues.  Although  half of the sample  inter-
viewed did not accept biotechnologies in general and GM  foods in particlllCll; 
there was rather high approval of  some specific health and economic benefits. 
About 80 percent of  the sample interviewed lack cOI?fidence  in existing gov-
el"l1l1lent regulatory :,ystems probab(v due to inadequate capacity.  Upgrading 
of  the existing regulatory system with adequate capacity to regulate the ethi-
cal and moral issues associated with biotechnologies and GM  foods was rec-
ommended 
Introduction 
Public perception of  agricultural biotechnology has been thoroughly inves-
tigated  in  industrialized countries  (Shanahan,  J.,  D.  Scheufele  and E.  Lee, 
200 I ; Gaskell et ai, 2000). However, not much is known about public attitudes 
in  developing countries. The worldwide application of biotechnology in the 
production of food,  fiber and phannaceutical is  a major development of the 
late 20th century. This emerging technology is often viewed as the next revo-
lution  which  has  the  potential  to  fundamentally  alter the  way the  society 
organizes its production and distribution of food. TAILORING  BIOTECHNOLOGIES 
Globally, billions of dollars have already been invested  in  biotechnology 
research and  new product development. Science and Technology is poised to 
bring consumers a wide range of  genetically modified (GM) products. In fact, 
many GM products have already entered the food distribution chains.  These 
products have the potential to not only meet the basic needs, but also bring a 
wide range of economic, environmental and health benefits. 
Despite the  numerous  benefits  associated  with  biotechnology,  its  public 
acceptance  has  been  with  mixed  feelings  (Einsiedel,  1997;  Aerni,  1999; 
Kalaitzandonakes, 2000; Sagar et a/. , 2000; Shanahan et a/., 200 I; I-Iallman et 
a/. , 200 I). In the public debates on biotechnology, four main issues have been 
raised including socio-economic, intrinsic value of  nature, environmental pro-
tection and regulatory system. 
Regarding socio-economic,  biotechnology advocates emphasize the poten-
tial  benefits to  society via  reduction of hunger and malnutrition,  prevention 
and cure of diseases, and promotion of health and  general well being of soci-
ety. This group maintains that the benefits of  modern genetic technologies will 
rather  improve  food  security  and  help  alleviate  poverty  (Watanabe,  1985; 
Isserman, 200 I; Hamstra 1998 and Hossain  et a/., 2002). On the other hand 
some argue that modern genetic technologies may allow developed countries 
produce commodities that are currently imported from developing countries. 
Such  developments,  it  is  claimed,  will  have significant  negative etTects  on 
poverty situation in the Third world and lead to global instability (Junne,  1991; 
Galhardi,  1995).  Another source of concern is that if biotechnology develop-
ments  are  not  tailored  to  local  conditions,  most  fanners  will  eventually 
become permanently dependent on multinational corporations for their "means 
of  production"  which  may  bring  adverse  socio-economic  outcomes 
(Ruivenkamp, 2005; Feenberg, 2005). 
With respect to intrinsic value o/nature,  the use of  biotechnology has been 
criticized as a needless interference with nature that may lead to  unknown and 
potentially disastrous consequences.  Biotechnology is often  criticized on the 
ground  that  its  use  in  plants  and  animals,  especially  gene  transfer  across 
species, take us to "realms of  God" and against "Law of  Nature".  Arguing fur-
ther,  genes are seen as naturally occurring entities that can be discovered (not 
invented),  granting  patent  ownership  to  genetic  findings  and  processes  is 
morally and ethically untenable. Consumer acceptance of biotechnology has 
been found to be significantly related not only to their perceptions of  risks and 
benefits associated with GM products, but also to their moral and ethical views 
(Moon and  Balasubramanian,  2004  and  Baker and  Burnham 200 I).  III  the 
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environmental protection and regu!atOlY debates.  some resist the use of genet-
ic technologies in agricultural production alleging (perceived) risks to humans 
and environment, while others question the level of trust in government bod-
ies to regulate its use. 
In  Ghana, very  few  studies have systematically explored the underlying 
factors int1uencing the acceptance of food  biotechnology among consumers. 
This article therefore proposes to bridge the knowledge gap on public percep-
tion of agricultural biotechnology in developing countries. 
Objectives 
This study explored the underlying factors influencing  public perception 
and consumer attitudes towards food biotechnology with the following specif-
ic objectives: 
I. To determine the level of acceptance and attitudes towards GM foods in 
Ghana 
2. To  investigate  the perceived health and economic benefits 
3. To examine public skeptism/fear  and optimism about biotechnology 
4. To establish the level of public/consumer confidence in government reg-
ulatory  systems 
5. To recommend ways to improve public acceptance of biotechnology 
Methodology 
The formation of an individual's perception of the risks and benefits  of a 
new technology is a very complex process determined by the selected sources 
of information, values, interests, and personal  experience. In the case of agri-
cultural biotechnology, most people cannot count on personal experience but 
must rely entirely on the information they receive. These sources of informa-
tion can be  rumors, experiences of people that work in  the field, statements 
issued  by  the  industry, government,  public interest groups or the academia, 
and, most important, media reports. Based on  the socially communicated val-
ues, the social status, and the professional affiliation, a person regards the dif-
ferent sources of information to be trustworthy. The selection of sources of 
information is also strongly  influenced by ones personal worldview or inter-
ests. This implies that given answers on  potential  risks on  biotechnological TAILORING  BIOTECHNOLOGIES 
products  should  be  interpreted  as  answers  which also  reflect  the  personal 
adherence to specific worldviews, judgments on the information sources, etc. 
The investigation of public perception in a particular country can therefore be 
conducted by means of  a representative survey where the respondents are cho-
sen at random, or it can focus on those political actors who form  public opin-
ion and claim to  represent certain public and  private interests.  The later may 
not necessarily focus on an  assumed representative judgment but rather indi-
cate some influential factors in the debate on public perception ofbioteclmologies. 
The Stakelwlder Approach 
This study employed  the stakeholder approach to  investigate public per-
ception and  consumer attitudes about agricultural  biotechnology  in  Ghana. 
This approach allows conducting a survey on public risk perception in a coun-
try  with  low awareness  of agricultural  biotechnology.  It also  allows  going 
beyond simple questions designed for consumers who are hardly familiar with 
agricultural  biotechnology and its  environmental, health and socioeconomic 
risks and benefits. The ditIerent stakeholders or consumer segments covered 
include  academia,  Non-governmental  organizations,  business  community, 
government and others. 
Sources ofDa{(1 (fnd Ana ~ysis 
A structured questionnaire was designed for data collection on  public atti-
tudes towards various issues pertaining to the use of biotechnology in agricul-
ture. These  included  subjects such  as  approval  of genetic  modifications of 
plants and animals to develop products that will bring specific health and eco-
nomic benefits, moral and ethical concerns about plant and animal genetics, 
perceptions of health and environmental risks associated with biotechnology, 
and wiJlingness to  accept GM food  products. Information was also collected 
on consumers' socio-economic and value characteristics. In  addition, the sur-
vey elicited respondents' confidence in  the government's ability and willing-
ness  to  protect public  interest.  To  obtain  an  objective measure of scientific 
knowledge  of respondents,  some  basic  questions  on  science  relating  to 
biotechnology were asked. The responses to  these questions were evaluated 
and the number of  correct responses used as the measure of their understand-
ing of  science. 
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A total of 100  people were interviewed. The target sample frame was the 
Ghanaian adult civilian population (18 years or older) in  the differlent stake-
holders  or consumer segments covered.  Statistical  Package  for  the Social 
Sciences (SPSS) and Microsoft Excel were used to analyze the data collected 
for discussion. 
Survey findings 
Socio-economic profile of  Respondents lIlId Know/edge olBiotechnology 
Table  l  presents  the  socio-ecol1ol71ic  p/'(~fi/e  of respondents  and  their 
knowledge  about  biotechnology  and  GM  teclmology.  There  Wc\'s  a  high 
response from  academia (Lecturers and Students), which could be attributed 
to the fact that the people in  this category have easy access to iOfol):nation on 
biotechnology and GM  technology.  The same could be said for gOvernment, 
which  had  people  from  areas  such  as  Food  and  Research  I),)stitQte  (FRI), 
Ghana  Standards  Boards,  Food  and  Drugs  Board,  and  Nuguchi  Memorial 
Institute for Medical Research (NMIR) who deal with biotechnology on daily 
basis.  The response to  the question on the  knowledge of Biotechnology and 
GM  foods  was  100  percent  and  95.3  percent  respectively.  'fhis  was  very 
impressive, suggesting that respondents were  in  good  position  to  give good 
judgmentlviews on the research topic and did not depend on heDrsay. 
Table  1 Socio-Economic  Proliles And  Knowledge of Biotecht)ology Of 
Respondents 
Chllrllcterist"ics  'Yo  Response  Characteristics  %  Respollse 
Occup:ttioll  Kllowledge Oil GM foods 
Acadcmia  45.3  Ycs  953 
NGO  8 I  No  3 5 
Business  14 ()  No response  I ? 
Government  23.3  I  M.~~!~tancc ofGM food  in 
Others  9.3  Ycs  44.2 
Gender  No  50.0 
Males  67.4  No response  5.8 
Females  32.6  Agllillst GM tilOds  011  reli-
I  ITious "rounds 
Knowledgc of Biotech  Yes  16.3 
Yes  100.0  No  83.7 
No  0  (;overnmcnt support for 
Biotech Rescarch 
Yes  84.9 
No  11.6 
No response  3.6 
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Level ofaccepta/lce and attitudes towards GMfoods in Ghana 
Examining responses on acceptance of GM in  Ghana, half of the sample 
interviewed was not in favor ofGM. They believed that the acceptance ofGM 
would make farmers loose focus on  the traditional way of cultivating putting 
the whole nation at the mercy of protit driven foreign companies who produce 
GM foods "This would be disastrous for the economy". Again, research insti-
tutes are not well equipped to deal with the issues concerning GM foods. Some 
respondents cited  an  example of a  recent  case  that occurred  in  the  Unites 
States where a  GM  producing company sent a  farmer to  court for keeping 
some of  the crops he bought from the company on an earlier date and planting 
the rest later on a latter date instead of going to  buy new crops for planting as 
agreed in  the contract. As explained in  the methodology, personal experiences 
and access to the right information on biotechnology could influence respons-
es to questions posed in this study. 
Close to 6 percent of the sample interviewed who were indecisive simply 
did not have adequate knowledge on the benefits and negative impacts associ-
ated with GM technology Majority (84.9%) however believed that any deci-
sion on GM should be supported with a thorough research base in  the home 
country. About 16 percent of the sample interviewed was against GM foods on 
religious grounds and cultural influences.  Table 2 presents results on  protec-
tion  attitudes of various consumers towards biotechnology.  It was revealed 
that a greater percentage of the respondents in  the other categories -those who 
are not in  academia, government or business-are unwilling to  accept GM as 
part of  meals to hospital patients. The response ranges fi'om as low as 27.8 per-
cent by academia through to 50 percent by other stakeholders. 
Table 2 Self-protection attitudes by the various consumer categories 
Self protection attitudes  'Yo  Yes  Response by Category 
Acade- NGO  Govern- Business  Others 
mla  ment 
Meals to needy children  50.0  57.1  68.4  50.0  50.0 
Meals to homeless in shelters  58.3  42.9  73.4  50.0  75.0 
Meals to hospital patients  27.8  42.9  33.3  41.7  50.0 
Food to war torn countries  66.7  71.4  78.9  58.3  62.5 
Meals to prisoners  52.8  71.4  78.9  50.0  75.0 
Food to friends  41.7  28.6  47.4  33.3  75.0 
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They also did not approve GM as part of food to friends except for the rather 
high affirmative response (75  percent) from other stakeholders. The  percep-
tion  pattern is  illustrated in  figure  I.  This takes into  account the percentage 
mean  of the  responses  from  the  various  consumers of GM  foods  (all  five 
stakeholders  ). 
Figure 1 Percentage pooled mean of stakeholders self protection attitudes 
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Perceived Health and Economic Bene/its 
Table 3 presents results  on  various consumer categories' views on  health 
and  economic  benefits of GM  foods/technology.  Generally  there  was  high 
approval of health and economic benefits of GM technology ranging from 50 
-100 percent by all the stakeholders except for some few  instances where the 
approval was just below the average percentage. Other stakeholders attained 
the highest approval (75-100 percent) for all  the  instances stated where GM 
teclmology could be used; this was followed by Academia, which had the next 
highest approval ranging from 52.8 - 80.6 percent.  The pattern of  approval of 
other stakeholders  and  Academia  is  similar to  that of NGO,  Business  and 
Government except for GM technology  in  creating  better tasting fruits  and 
vegetables  where  there  was  a  low  approval  of 47.4  percent  by  the 
Government. Also GM technology for creating less expensive fruits and veg-TAILORING  BIOTECHNOLOGIES 
etables received a relatively low approval of  42.9 percent and 47.4 percent by 
NGO and Government respectively. 
One would expect that the approval ofGM technology for creating insulin 
should be low but in  this case it's rather the opposite with  the following per-
centages; Academia (74.3  percent), NGO (85.7  percent), Government (84.2 
percent),  Business (75.0 percent, Other stakeholders (87.5  percent). The  line 
graph in  figure 2  illustrates the  percentage  pooled mean of approval of GM 
technology by the stakeholders. This graph shows that GM technology has a 
high percentage approval from all  the stakeholders with regards to health ben-
etlts, especially in creating rice with enhanced vitamin 1\  and  insulin for dia-
betic patients. 
Table 3 Health and Economic Benefits of GM technology 
Health &  Economic  Benefit  t v.. Yes  Response hy Category 
Govcrn- Othcr 
Acadcmia  NGO 
ment  Busincss  stakehold-
ers 
Ricc with  Enhanccd Vit A  RO.6  R5.7  R4.2  66.7  R7.5 
More  Nutritous Grain  77.R  714  77.R  50.0  100.0 
Bettcr taste in  Fruits &  52.X  R5.7  474  50.0  R7.5  Vcgatablcs 
Lcss Expcnsivc fru its and 
52.R  42.9  474  5R.3  75.0  Vcgatables 
Insulin  for Diabetic Patients  74.3  R5.7  R4.2  75.0  R7.5 
Sheep Milk 10 1'  Mcdicines  66. 1  R5.7  6R4  50.0  75.0 
Less mowed Grass  72.2  42.9  73.7  66.7  75.0 
Less perishable  fruits & 
62.9  85.7  474  58.3  75.0  Vegatables 
Less Cholesterol  beef  6 1.1  714  43.7  66.7  62.5 
High Milk yielding Cows  52.R  42.9  52.6  58.3  87.5 
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Figure 2 Percentage pooled mean response from stakeholders concerning 
health and economic benefits of GM technology. 
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Skepfi.l'lI1lFear alld OptillliSIII  {/hollt Biotechl1ology 
Results  on respondents' views on Skeptism/fear about  biotechnology arc 
presented in  table 4.  All  consumer categories were not  willing to accept GM 
technology  if it's against nature despite  the advantages. The  percentage Yes 
response to  this question ranged hom 25  percent by  business through to 50 
percent by  NGO and other stakeholders.  Most of them agreed that some GM 
technology threatened nature and  thus there was a need for regulations given 
GM  potential dangers. 
Respondents however did  not strongly agree to  the ract that nature should 
be  left as  it  is. Government  had  a weak agreement  of 26.3 percent  and some 
officials  interviewed  were  of the  view  that  it's  highly  impossible  to  leave 
nature as it is since we depend on it for human survival thus if there are regu-
lations to check GM we could go ahead and exploit nature but in  a controlled 
manner. On the other hand, NGO had a high agreement percentage of66.7 per-
cent of leaving nature as it  is.  This  is because it consisted of members from 
Friends of the Earth, an NGO concerned with  the conservation of nature. 
Buying  from  non-GM  food  shops  only,  received  a  negative  response; 
Academia (45.5  percent), NGO (28.6  percent), Government  (2 1.1  percent), 
Business (16.7 percent) and others (14.3 percent). A greater percentage acrOSS 
consumer categories did not agree that serious GM accidents are bound to  h~g-TAILORING  BIOTECHNOLOGIES 
pen (57.1 - 91.2 percent). Most of them were also unwilling to petition against 
GM and did not really mind if served GM foods unknowingly in  restaurants 
(50 - 7]  percent).  When asked whether they believe that GM products created 
by scientist are  public driven there  was  neither a strong agreement nor dis-
agreement i.e. a little below and above the average percentage response across 
consumer categories. Again the  impressions created here suggest that people 
have questions about how these biotechnologies are developed. Figure 3 illus-
trates  the  percentage  pooled  mean  of  stakeholders'  fearlskeptism  about 
biotechnology. 
Respondents were optimistic about the  prospect of biotechnology  if  the 
associated risk is well  managed; for example new and improved food and fiber 
that can bring a wide range of health and economic bend-its to society. Table 
5 depicts optimism about biotechnology by the various consumer categories. 
GM crops were believed to have brighter business future; Academia (73.3 per-
cent), NGO (50.0 percent, Government (63.2 percent), Business (41 .7 percent) 
and  Other  stakeholders  (75.0  percent).  All  the  consumer categories  except 
Business did not agree  that scientist know better and  it can  be  seen  clearly 
from the following percentages; Academia (40.5 percent), NGO (0.0 percent), 
Government  (25.0  percent),  Business  (58.3  percent),  Other  stakeholders 
(37.5.0 percent). Other stakeholders strongly answered No to  GM risks being 
exaggerated. The rest were a little above the average percentage with business 
taking the lead with 58.3 percent. 
A very high positive response to the participation in GM public debate can 
be seen hom table 5 ranging tI'om 66.7 - 100 percent. Also most respondents 
seem to watch TV and read about GM biotechnology, which is a good sign that 
they  might  have  reliable  sources  of  information  about  GM  technology 
although the opinions ofthese T.V watchers may not be very representative for 
the  whole  Ghanaian  popUlation.  Figure  4  illustrates  the  percentage  pooled 
mean of stakeholders' optimism about biotechnology. 
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Table 4 Skeptism about Biotechnology 
SkCI)tism and fcar about  'Xl  Ycs  Response by Category 
biotech 
Other 
Acadcmia  NGO  Govcrn- Business  slakehold-
ment  ers 
GM advantage but against  35.3  50.0  40.0  25.0  50.0 
nature 
GM threatens nature  65.7  57.1  70.0  5R.O  37.5 
Leave nature  47.9  66.7  26.3  5R.3  -
Regulations ror GM  97.2  X5.7  90.0  R3.3  100.0 
Buy rrom non-GM  rood ~ 
shops  45.5  2R.6  21.1  16.7  14.3 
GM companies care for profit  55.9  R5.7  52.6  66.7  14.3 
Serious GM  accidents  91.2  71.4  6R.4  72.7  57. 1 
Petition against GM  37.1  57. 1  31.6  41.7  25.0 
Unhappy  when  served  GM 
6R.6  71.4  60.0  75.0  50.0 
rood 
GM is public driven  41.7  57.1  61 .4  66.7  42.9 
Figure 3  Percentage pooled mean response frolll  stakeholders concerning 
their skeptism/rear about biotechnology 
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Confidence in  Government Regulatorv S)I.I'tem 
With regard to the level of confidence in  government regulatory system in 
the area of biotechnology, all consumer categories had very low confidence in 
government organizations such as the Food and Drugs board and the Ghana 
Standards Board. Moreover, there was a little confidence in  research institu-
tions  such  as  Food  and  Research  institute  (FRJ)  and  Noguchi  Memorial 
Institute for Medical Research (NMIR). Most of  respondents were of the view 
that the government institutions are not well equipped to handle GM technol-
ogy. Hence the high positive response to  the need  to establish a special body 
to  regulate ethical and moral  issues associated with  biotechnology research. 
The pattern of response is  well illustrated in the line graph in  Figure 5 
Table 5 Optimism about Bioteclmology 
Optimism About Biotechnology  'Yo  Yes  Response by Category 





QM crops have brighter business 
future 
73.3  50.0  63.2  41.7  75.0 
Scientist know better  40.5  0.0  25.0  5R.3  37.5 
GM risk are exaggerated  43.2  50.0  55.0  58.3  12.5 
Participate in GM public debates  75.0  R3.3  R5.0  83.3  62.5 
Read/watch TV about GM tech- 78.4  66.7  n.9  R3.3  100.0  nolol'v 
Figure 4 Percentage pooled mean response from stakeholders concerning 
their optimism about biotechnology 
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GENERAL DISCUSSIONS,  CONCLUSIONS  AND  RECOMMEN-
DATIONS 
General Discussions {lnd Condllsio/1s 
Despite  major scientific  progress  in  the application of biotechnology in 
agriculture,  public attitudes towards biotechnology in  general  and GM  food 
products in  particular remain mixed,  Examining responses on acceptance of 
GM  by selected stakeholders in  Ghana, survey findings established that half 
of the sample interviewed was not in  favor of GM foods. They believed that 
the acceptance of  GM foods would make farmers loose focus on the tradition-
al way of  cultivating putting the whole nation at the mercy of profit driven for-
eign companies who produce GM foods, 
There  was  high  level  of self protectionist  attitudes  on  the  part  of the 
respondents.  While majority were cautious of being served with  GM  foods 
they remained inditTerent if served to needy children, the homeless, food aid to 
war torn countries and  prisoners who do not have a choice. Respondents had 
the notion that needy children, the homeless, war torn countries and prisoners 
have no choice thus if GM foods can feed them why not, yet with friends and 
hospital patients other factors must be considered (e.g. side effects  ofGM foods). 
Surprisingly, there was overwhelming approval of  specitic health and eco-
nomic benefits of GM technology especially, in  creating rice with enhanced 
vitamin A and insulin for diabetic patients. This rather high approval of GM 
technology for creating insulin and vitamin A for  patients conflicts with the 
negative  attitude of respondents  to  GM  foods  as  part  of meals  to  hospital 
patients. Such contlicting results suggest the need for more awareness creation 
and intensive education on biotechnological issues in Ghana, 
Respondents were concerned about the perceived health, safety and envi-
ronmental risks often associated with the use of biotechnologies. A signi ficant 
percentage of the respondents were not willing to accept GM technology if it's 
against nature despite the advantages, They agreed that some GM technology 
threatened nature and thus there was a need  for regulations given GM  poten-
tial dangers. However, public confidence in  the existing government regulato-
ry  systems was very low and  therefore a  request was  made for a  complete 
replacement or adequate capacity building of the existing ones to regulate the 
ethical and moral issues associated with biotechnology research, Respondents 
were however optimistic about the prospects of biotechnology if the associat-
ed risks are well managed, TAILORING  BIOTECHNOLOGIES 
Figure 5 Percentage pooled mean response from stakeholders concerning 
their confidence in government rerrulatory system 
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Recommendation.\' 
Two key recommendations are worth considering. First, there is  the need 
for more tailor-made research inputs in order to make concrete informed deci-
sions on the Ghanaian situation. Secondly, a  regulating body which is  ade-
quately equipped should  be  placed over large genetic  companies for proper 
control  and  to  avoid  monopoly  or  exploitation  of the  potential  market. 
Alternatively,  measures should  be  taken  to  upgrade  the  existing  regulatory 
systems so as to  boost public confIdence in  them 
References 
Aerni. P.  (1999), "Public Acceptance or  Transgenic  Rice and  its  Potential Impact  on  Future Rice Markels in 
Sout heast Asia"  Ph.D.  Dissertation. Zurit..:h: Swiss  F\;dcral  Institute or Technology. 
Baker, G.  A. and T. A. Burnham. (200 I). Consumer Response to Genetically lvioeli lied  I':ooels:  lviarket Segment 
Analysis and Implications for  Producers iJne!  Policy Makers. jOlfrfw/l!/Agl'icllllllra/ (/1/(/ Resollrce 
Ecollolllics. 26: JR7-403. 
Einsicdcl.  F. F.  (1997). BiOf(,c/1II0/ogy (l1/(/llte C{/I/m/hlll Puh/ic.  Report  Oil  i.l 1997 Nation:i1  Survey and Some 
International Comparison. University ofCalgnry. Calgary.  Canada. 
Fccnberg. J\  (2005) Critical theory of Techno logy: j\n Overview: Tailoring Biotechnologies Potentialities. 
Actualities and Spaces Vol. I.  Issue  I, p47-64 
PUBLIC  PERCEPTION  AND  ATTITUDES  TOWARDS  AGRICULTURAL  BIOTECHNOLOGY  IN  GHANA 
Galhardi. R.  M.  (1995). "Employment Impacts 01' Agrieulturnl  Biotechnologies in  Latin America: ('oncc :1I1d 
Cocoa in Costn Rica". In Assessillg lite flJI/wels (!/"/lgriclI/lllrll/ Bio/(!c//1/%gies. edited by B.  Ilcrbert-Coph.:y. 
Proceedings oCMeding of International Development Research Center (lORe), May  15-16. Ottav.ln, Canada. 
Gaskell. G" N.  Allum. M. Uaucr  . .I.  Durant. A. AII:lllseiollir.  II. llonl;ldelli.  D.  Boy, S. de (,heveigne, B.  Fjaestad, 
.I. M.  Ciulleling,.I.  Ilampel, E. .klsoe,.I. C  .ksuina, M.  Kohring,  N.  Kronbcrger, C  Midden, T.  II.  Nielsen, 
1\. Przcstalski, T.  Rusarc ll. C, Sakcllaris,  II. Torgersen, T. Twardowski, and \V,  \Vagner.  (2000). 
"[3iotedlllology and the  l ~ urope;111 public". Nalure Bio{L'c/lIIu/oJ{Y.  IX(l)): 9J5-93R. 
Ilalllll<lll,  V/., 1\. I\ddaja.  B.  Schilling. anti  J.  T  Lang, (200 I).  ('OllsllIIle/,  !3c1i<.'f.~·.  AI/ill/des lIlId Preji..'rL'IICL'S 
Regarding Agrh'lIlfllra/ lJiolL'c/IIIO/ogl'. FoOl.1  Polil:Y  Institutl!  Report,  Rutgers University.  New  Brunswick. 
New Jersey  . 
11:1I115tr:l.  L A. (I 99R).  Puh/ic Opillio/l  (/hOllf  BilJlec/l/lO/ogy: A .\'IIF1'Cy (!F5;lIn'e.rs,  Europl.!<In 1 ;I.!(kralion or 
Biotechnology Task Croup on  Public Perceptions on Billtechn()logy, The Ilaguc. Till!  NctlH.::rlands,  19, 
Ilaban. T  ( 190X ).  Trends in  consumer attitudes about agricultural biotechnology,  Ag/JioForlllll.  I (I). Avai lable 
on the  \Vorld \,Vide 'Web:  http://www.agbiofonllll .org, 
Iloss;lin  F.,  13,  Onyango.  A,  Adl.!laja.  B.  Schilling and  \~1.  Iiallm<ln (2002). Unc()vl!ring F;H.:tl>rS IntlLlcncing 
Public Perceptions or Food Biotechnology.  Food Policy Inslitute. vVorking Paper.  JUlle 2002, 
Isscrll1an. A.  M. (200 1). Genetica lly Modilicd  Food: Understanding the Social Dilcllllll'.l. ;/II/eric(/fl lJd/(/l'inr(// 
SciclIli,,'. 44: I 225-1232. 
.Illn",. C  (2002). "The Glohal  Sustainability (,1",l lcnge: Frolll Agreement tu Action".  Int. .l.  Global 
Environlllent::li  IsslIes 2.  1/2 :  1- 14 . 
.lunrx::.  (i. (199 I). The  l mp~lct s or Biotechnology 011  International Tr:l(k, In /3io{l'c/lll%,';y in PcrsjJL'c1in': 
SOciO-CC()1I0fllic  /111/dicu{;ol/sjiw DCI'C/o/)illg  COlllllri('s,  Edited by 1\. Sasson iJnd  V.  Costarini, Paris:  Unih.:d 
Nations I':clucational, Scientilic and ('ultmal Organization (UN I'SCO). 
Kala i l z~lI1dollakcs (2000) I\grobiolechnology and  ('(lmpctit i venc~s. IJII/(:l'iclIll.lol/u/(//I!(Agrh·/Ilf11rll/ 
Eco//olllics  ~Q I 5:  1224- 1233. 
Moon,  Vv ..  & l3alasubrami.lIlian. S.K.  (200 I),  Public perccptions ,lIld  willingness-ttl-pay a premium for nOIl-(iM 
Fuods in  the US  and  UK.  AgBi()f.'()/'IIII/. 4(3&4) 22 1-2:1 1. Available on  the World  Wide Wcb: 
Ilttp:I/VoiWW.,lgbiol()rUln.org. 
Moon, vv..  &  Balasubramanian, S.l(. (2004). Public allitudes toward agrobiotcchnology: The mediating role or 
risk  perceptions on  the impact  0 1' trust, awa re r~ss. and outrage.  Redell' (~r / l t?ric/{If /l "(//  /~c o//()lIIics. 26(2). 
I g6-20R 
Ruivcnkamp. (j. (2005), Between Bin-Power and Sub-Politics Tailoring Biotechnologies:  Potentialities, 
Actualities and Spaces Vol. I  Issue I. p 11 -32 TAILOR I NG  BI OTECHNOLOGIES 
Sagar. ."  .. Daemmrich ..  \ and Ashi'·a. 'd. (2000) The tragedy of the commoners: biotecbnology and its publics. 
COl11m~ntary  . .  \ '({(lIre Biotechnology.  \'01  I R.  January  :WOO. 
Shanahan. J  ..  D.  Scheul;'le and E.  Lee. 2001. "Trends: ."Hirudos about Agricultural Biotechnology and 
Genetically ~ I odilied Organisms'. Pllhlic O"illioll  QIIII}'{e"~1' 65 (2):  267-R I. 